Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

被引：58

作者：

Fendler, Annika ^{[1
]}

Shepherd, Scott T. C. ^{[1
,14
,15
]}

Au, Lewis ^{[1
,14
,15
]}

Wu, Mary ^{[2
]}

Harvey, Ruth ^{[3
]}

Schmitt, Andreas M. ^{[14
,15
]}

Tippu, Zayd ^{[1
,14
,15
]}

Shum, Benjamin ^{[1
,14
,15
]}

Farag, Sheima ^{[14
,15
]}

Rogiers, Aljosja ^{[14
,15
]}

Carlyle, Eleanor ^{[14
,15
]}

Edmonds, Kim ^{[14
,15
]}

Del Rosario, Lyra ^{[14
,15
]}

Lingard, Karla ^{[14
,15
]}

Mangwende, Mary ^{[14
,15
]}

Holt, Lucy ^{[14
,15
]}

Ahmod, Hamid ^{[14
,15
]}

Korteweg, Justine ^{[14
,15
]}

Foley, Tara ^{[14
,15
]}

Barber, Taja ^{[1
]}

Emslie-Henry, Andrea ^{[1
]}

Caulfield-Lynch, Niamh ^{[1
]}

Byrne, Fiona ^{[1
]}

Deng, Daqi ^{[1
]}

Kjaer, Svend ^{[4
]}

Song, Ok-Ryul ^{[2
]}

Queval, Christophe ^{[2
]}

Kavanagh, Caitlin ^{[2
]}

Wall, Emma C. ^{[2
,23
]}

Carr, Edward J. ^{[5
]}

Caidan, Simon ^{[6
]}

Gavrielides, Mike ^{[7
]}

MacRae, James I. ^{[8
]}

Kelly, Gavin ^{[9
]}

Peat, Kema ^{[14
,15
]}

Kelly, Denise ^{[14
,15
]}

Murra, Aida ^{[14
,15
]}

Kelly, Kayleigh ^{[14
,15
]}

O'Flaherty, Molly ^{[14
,15
]}

Shea, Robyn L. ^{[16
,24
]}

Gardner, Gail ^{[16
]}

Murray, Darren ^{[16
]}

Yousaf, Nadia ^{[17
,18
]}

Jhanji, Shaman ^{[19
]}

Tatham, Kate ^{[19
]}

Cunningham, David ^{[20
]}

Van As, Nicholas ^{[21
]}

Young, Kate ^{[14
,15
]}

Furness, Andrew J. S. ^{[14
,15
]}

Pickering, Lisa ^{[14
,15
]}

机构：

[1] Francis Crick Inst, Canc Dynam Lab, London NW1 1AT, England

[2] Francis Crick Inst, High Throughput Screening Lab, London NW1 1AT, England

[3] Francis Crick Inst, Worldwide Influenza Ctr, London NW1 1AT, England

[4] Francis Crick Inst, Struct Biol Sci Technol Platform, London NW1 1AT, England

[5] Francis Crick Inst, Cell Biol Infect Lab, London NW1 1AT, England

[6] Francis Crick Inst, Safety Hlth & Sustainabil, London NW1 1AT, England

[7] Francis Crick Inst, Sci Comp Sci Technol Platform, London NW1 1AT, England

[8] Francis Crick Inst, Metabol Sci Technol Platform, London NW1 1AT, England

[9] Francis Crick Inst, Dept Bioinformat & Biostat, London NW1 1AT, England

[10] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London NW1 1AT, England

[11] Francis Crick Inst, Neurodegenerat Biol Lab, London NW1 1AT, England

[12] Francis Crick Inst, Struct Biol Dis Processes Lab, London NW1 1AT, England

[13] Francis Crick Inst, RNA Virus Replicat Lab, London NW1 1AT, England

[14] Royal Marsden NHS Fdn Trust, Skin Unit, London, England

[15] Royal Marsden NHS Fdn Trust, Renal Unit, London, England

[16] Royal Marsden NHS Fdn Trust, Dept Pathol, London, England

[17] Royal Marsden NHS Fdn Trust, Lung Unit, London, England

[18] Royal Marsden NHS Fdn Trust, Acute Oncol Serv, London, England

[19] Royal Marsden NHS Fdn Trust, Anaesthet Perioperat Med & Pain Dept, London, England

[20] Royal Marsden NHS Fdn Trust, Gastrointestinal Unit, London, England

[21] Royal Marsden NHS Fdn Trust, Clincal Oncol Unit, London, England

[22] Royal Marsden NHS Fdn Trust, Haematooncol Unit, London, England

[23] Univ Coll London Hosp NHS Fdn Trust, Biomed Res Ctr, London, England

[24] Inst Canc Res, Translat Canc Biochem Lab, London, England

[25] Inst Canc Res, Melanoma & Kidney Canc Team, London, England

[26] UCL, Div Med, London, England

[27] UCL, Inst Canc, London, England

[28] UCL Queen Sq Inst Neurol, London, England

来源：

LANCET | 2022年 / 399卷 / 10328期

关键词：

D O I：

10.1016/S0140-6736(22)00147-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：905 / 907

页数：3

共 50 条

[41] Acute myocarditis after a third dose of the BNT162b2 COVID-19 vaccine
Fosch, Xavier
Serra, Julia
Torres, Pedro L.
Preda, Luminita
Gonzalez, Rosa
Mojer, Francisca
REVISTA ESPANOLA DE CARDIOLOGIA, 2022, 75 (07): : 614 - 616
[42] Longitudinal age differences in humoral responses to the COVID-19 vaccine in the elderly are lost after the third dose
Pozo-Balado, Maria del Mar
Bulnes-Ramos, Angel
Garrido-Rodriguez, Vanesa
Olivas-Martinez, Israel
Lozano, Carmen
Gonzalez-Escribano, Maria Francisca
Leal, Manuel
Pacheco, Yolanda M.
JOURNAL OF INFECTION, 2023, 86 (02) : 172 - 174
[43] Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273
Barei, Francesca
Marletta, Dario A.
Marti-Marti, Ignasi
Maronese, Carlo A.
Genovese, Giovanni
Marzano, Angelo V.
DERMATOLOGIC THERAPY, 2022, 35 (08)
[44] Stevens-Johnson syndrome in an Asian man after receiving the third dose of COVID-19 vaccine
Ho, Chih-Yi
Wang, Huei-Jing
Cheng, Yu-Wen
Chen, Chun-Bing
Lan, Cheng-Che
Chen, Yang-Yi
DERMATOLOGICA SINICA, 2024, 42 (04) : 305 - 306
[45] Myocarditis After the Third Dose of mRNA-1273 Coronavirus Disease 2019 (COVID-19) Vaccine
Kawahara, Hiroshi
Endo, Akihiro
Yamaguchi, Kazuto
Yoshitomi, Hiroyuki
Tanabe, Kazuaki
CIRCULATION REPORTS, 2022, 4 (08) : 388 - 389
[46] A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching
Lee, Jenny M.
Sachithanandham, Jaiprasath
Lee, John S.
Shapiro, Janna R.
Li, Maggie
Sitaris, Ioannis
Peralta, Stephanie R.
Wouters, Camille
Cox, Andrea L.
Segev, Dorry L.
Durand, Christine M.
Robien, Mark
Tobian, Aaron A. R.
Karaba, Andrew H.
Blankson, Joel N.
Werbel, William A.
Pekosz, Andrew
Klein, Sabra L.
MICROBIOLOGY SPECTRUM, 2025, 13 (03)
[47] Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine
Tangsathapornpong, Auchara
Nanthapisal, Sira
Pontan, Kanassanan
Bunjoungmanee, Pornumpa
Neamkul, Yamonbhorn
Boonyarangkul, Arthit
Wanpen, Supattra
Fukpho, Waraphon
Jitpokasem, Sumana
Tharabenjasin, Phuntila
Jaru-Ampornpan, Peera
VACCINES, 2023, 11 (03)
[48] Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy
Guven, D. C. C.
Incesu, F. G. Gulbahce
Yildirim, H. C.
Erul, E.
Chalabiyev, E.
Aktas, B. Y.
Yuce, D.
Arik, Z.
Kilickap, S.
Aksoy, S.
Erman, M.
Hayran, K. M.
Unal, S.
Alp, A.
Dizdar, O.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1279 - S1279
[49] Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy
Guven, Deniz Can
Incesu, Fatma Gul Gulbahce
Yildirim, Hasan Cagri
Erul, Enes
Chalabiyev, Elvin
Aktas, Burak Yasin
Yuce, Deniz
Arik, Zafer
Kilickap, Saadettin
Aksoy, Sercan
Erman, Mustafa
Hayran, Kadir Mutlu
Unal, Serhat
Alp, Alpaslan
Dizdar, Omer
INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (04) : 679 - 685
[50] Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
Solera, Javier T.
Ierullo, Matthew
Arbol, Berta G.
Mavandadnejad, Faranak
Kurtesi, Alexandra
Qi, Freda
Hu, Queenie
Gingras, Anne-Claude
Ferreira, Victor H.
Humar, Atul
Kumar, Deepali
LANCET INFECTIOUS DISEASES, 2023, 23 (08): : E266 - E267

← 1 2 3 4 5 →